Alopecia Areata Reframed as a Medical Disease, Not a Cosmetic Concern
Dermatology Times reframes alopecia areata as a medical, autoimmune disease, outlining how clinicians should define severity and match treatment options accordingly.
Topic
Hair Loss
Topic
Hair Loss
Expert Panel Releases Oral Minoxidil Consensus for Preteens
An expert panel has released a consensus statement aimed at clarifying oral minoxidil use in preteens, addressing an off-label pr…
Dermatology Times Publishes Clinician FAQ on Hair Loss Pipeline
Dermatology Times has published a clinician-focused FAQ on the hair-loss treatment pipeline, organizing investigational-therapy i…
New Study Points to Possible Biological Link Between GLP-1 Drugs and Hair Loss in Men
New research reported October 3, 2026 suggests a possible biological link between GLP-1 drugs like Ozempic and hair thinning in m…
Study probes genetic link between GLP-1 drugs and male pattern hair loss
Researchers have launched a genetic study testing whether GLP-1 receptor agonists share biological pathways with androgenetic alo…
Hair Growth Supplements: Dermatologists Say the Ingredient Decides
Dermatologists say hair growth supplements can work — but only conditionally, with outcomes determined by the specific ingredient…
Scalp Botox for Hair Loss: Doctors Assess South Korea's Latest Trend
Botulinum toxin injected into the scalp is being marketed in South Korea for hair loss, but physicians warn the evidence base rem…
Alopecia Areata Awareness Month: 2026 in Review
Alopecia Areata Awareness Month returns in 2026 as dermatology takes stock of a year in which visibility, patient advocacy and cl…